Introduction
Enchondromas are benign bone tumors originating from hyaline cartilage. These intramedullar cartilage lesions are believed to be hamartomatous remnants of the growing plate (1, 2) . They are solitary lesions located usually in the upper and lower extremities (3, 4) . While 40-70% of patients with enchondroma are localized in the hands and small bones in the legs, 25% of the cases are seen in long tubular bones (5, 6) . Diagnosis is usually made based on the presence of a painful or painless swelling, a pathological fracture or an incidental radiological finding (7) (8) (9) . These lesions are usually followed-up with conservative methods. When surgery is indicated, curettage and filling the space with bone graft or supportive materials are performed (5) . This retrospective study compared the preoperative blood values hematocrit (Hct), hemoglobin (Hgb), white blood cell (WBC), platelet (PLT), red cell distribution width (RDW), mean corpuscular volume (MCV), and the neutrophil/lymphocyte ratio (NLR)] between patients with enchondroma and the control group, and also investigated the location of the tumor in the patient group. Patients who had an inflammatory disease, diabetes, steroid use, alcohol use or who smoked were excluded from the study group. 
Material and methods

Results
The mean age was 24.7± 11.26 years for the patient group and 24 ± 16.38 years for the control group. There was similarity between groups according to age and sex (p>0.05) ( Table 1) . Although the number of neutrophils, lymphocytes, NLR, RDW and PLT were higher in the patient group, no statistically significant difference was found (p>0.05) ( Table 1) . The proximal phalanx was determined to be the most commonly involved site (Figure 1 ). Statistical analysis: Independent sample t-test was used to compare the parameters of the blood tests and the age and sex of the patients. Chisquare test was used for the localization of the enchondroma in the hand bones. Student's t tests were used to compare the parameters. The results were evaluated as mean ± standard deviation. The results were accepted as significant when p values less than 0.05. Statistical Package Program for Social Sciences (SSPS) was used for statistical analysis.
Discussion
When we checked the literature, we thought that these blood values are the first to study preoperatively in patients with enchondroma. Although this parameter in the complete blood count was higher in the patient group, it did not seem to be statistically significant. Enchondroma is a benign tumor of the hyaline cartilage. The lesions are commonly located within the bone. While the vast majority of the tumors are solitary, more than one bone or more than one location in one bone may rarely be involved (10) . Enchondromas are distributed almost equally in both gender and in each age group (4). 40-65% of the cases are seen in the small tubular bones of the hands, most frequently in the proximal phalanx, metacarpal bones, middle phalanx and rarely in distal phalanx (11) . They are seen in the middle and distal parts of the metacarpal bones and more in proximal part of phalanges. The tubular bones of the feet are involved seven-fold less frequently than the hand. Enchondromas are almost never seen in the carpal or the tarsal bones. While most of the enchondromas may be seen in the femur, humerus, tibia, radius, ulna and fibula are rarely involved, and flat bones are involved very rarely too (12) . Our study has revealed that involvement of the proximal phalanx is statistically significantly higher than the middle phalanx, distal phalanx and metacarpal bone (p<0.05) ( Table 2) . When the patients were investigated with regard to the involvement site in the hand, proximal phalanx involvement was determined to be statistically significantly higher than involvement of the middle phalanx, distal phalanx and the metacarpal bones (p<0.05) (Figure 1) . A potential relationship between systemic inflammation and malignancy development has gained great importance in recent studies (13) . Although the exact mechanism is not known, some hypotheses have been proposed. Tumorrelated inflammation may lead to increased level of cytokines, inhibition of apoptosis and increased angiogenesis. Tumor cells increase the granulocyte colony-stimulating factor (G-CSF) release, which triggers the increase in neutrophil count. Neutrophils play a role in tumor angiogenesis through producing pro-angiogenetic factors such as vascular endothelial growth factor, matrix metalloproteinase, interleukin-8 and elastases (14) (15) (16) (17) (18) . While these cytokine species contribute to tumor growth and metastases, lymphocytes have a significant role in tumor suppression (19). Increased lymphocyte count is known as a positive factor in colorectal cancer, breast cancer and melanoma (20-22). Both increased neutrophil count and decreased lymphocyte count may lead to increased NLR, which has been reported to a prognostic factor in many cancer types. Leukocyte migration is important in the physiological immune response and accompanies systemic changes triggered by circulating cytokines and chemokines. These changes may lead to increased neutrophil and platelet count and decreased lymphocyte count. These changes have been proposed to have an important role in growth, progression and metastasis of the neoplasm (23). Neutrophilia may develop as a result of infection accompanied by para-neoplastic myeloid growth factors or cancer-related inflammation (24) . Lymphocytes have an important role in defense against tumor through induction of cell death via the immune response. Lymphopenia is frequently seen in developed cancers and this is an indicator of a suppressed immune response due to cancer (25) . Therefore, neutrophilia and lymphopenia may be erroneous due to cancer progression. Elevated NLR may result from the systemic inflammatory response due to cancer, which could lead to neutrophilia and lymphocytopenia (26) . High WBC may be directly related to inflammation, especially in cardiovascular diseases (27) . NLR is nowadays defined as a marker of inflammation and is used as an index in cancer diagnosis and treatment (28, 29) . Elevated NLR is a prognostic factor in many cancer types (30, 31 (38) . Our study has not revealed a significant difference between the patient and the control groups with regard to NLR. This result may be associated with the small number of patients. Furthermore, enchondroma may not have affected the inflammatory parameters due to being a chronic disease, which progresses slowly. NLR has been used as a prognostic factor in recent studies. We suggest that NLR may be used as an inexpensive, non-invasive method for malignant transformation of enchondroma due to the potential for malignant transformation, although very rare. The NLR value may be useful for clinicians for this rare and insidious condition. Further studies with larger series are required for better understanding this issue.
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